Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence.

scientific article published on 10 May 2011

Improved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence. is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00253-011-3297-0
P698PubMed publication ID21556920
P5875ResearchGate publication ID51112069

P50authorGuocai ZhongQ30506931
P2093author name stringYan Li
Dan Yang
Hong Ling
Jia-Ye Wang
Wen-Ting Song
Hai-Zhou Zhou
Cai-Yun Ren
Hao-Tong Yu
Wen-Jiang Chen
P2860cites workCodon usage limitation in the expression of HIV-1 envelope glycoproteinQ24498729
DNA vaccines: improving expression of antigensQ24806169
Buried polar residues in coiled-coil interfacesQ27631954
A new expression system for protein crystallization using trimeric coiled-coil adaptorsQ27649374
A switch between two-, three-, and four-stranded coiled coils in GCN4 leucine zipper mutantsQ27731470
Buried polar residues and structural specificity in the GCN4 leucine zipperQ27734067
Crystal structure of GCN4-pIQI, a trimeric coiled coil with buried polar residuesQ27766102
Protein secondary structure prediction based on position-specific scoring matricesQ27860483
Improved prediction of signal peptides: SignalP 3.0Q27860548
The PSIPRED protein structure prediction serverQ27860953
A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1Q28752179
Patterns of amino acids near signal-sequence cleavage sitesQ29616542
Oligomeric modeling and electrostatic analysis of the gp120 envelope glycoprotein of human immunodeficiency virusQ33797989
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag geneQ33799802
Modifications that stabilize human immunodeficiency virus envelope glycoprotein trimers in solutionQ33804811
Characterization of stable, soluble trimers containing complete ectodomains of human immunodeficiency virus type 1 envelope glycoproteinsQ33806056
Enhancement of primary and secondary cellular immune responses against human immunodeficiency virus type 1 gag by using DNA expression vectors that target Gag antigen to the secretory pathwayQ33806715
Improved elicitation of neutralizing antibodies against primary human immunodeficiency viruses by soluble stabilized envelope glycoprotein trimersQ33836042
Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag proteinQ33849127
Evaluating the immunogenicity of a disulfide-stabilized, cleaved, trimeric form of the envelope glycoprotein complex of human immunodeficiency virus type 1Q33883887
Coiled coil domains: stability, specificity, and biological implicationsQ33975515
Polar side chains drive the association of model transmembrane peptidesQ34630825
DNA vaccines: ready for prime time?Q34824179
Highly stable trimers formed by human immunodeficiency virus type 1 envelope glycoproteins fused with the trimeric motif of T4 bacteriophage fibritinQ34999293
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heteroloQ35024202
The design of coiled-coil structures and assembliesQ36101270
Comparative efficacy of neutralizing antibodies elicited by recombinant hemagglutinin proteins from avian H5N1 influenza virusQ36747980
Foldon-guided self-assembly of ultra-stable protein fibers.Q36851698
Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimenQ37242521
Immunogenicity of HIV-1 envelope glycoprotein oligomersQ37667740
Effect of intron A from human cytomegalovirus (Towne) immediate-early gene on heterologous expression in mammalian cellsQ38334274
Biosynthetic protein transport and sorting by the endoplasmic reticulum and GolgiQ39664981
Oligomeric and conformational properties of a proteolytically mature, disulfide-stabilized human immunodeficiency virus type 1 gp140 envelope glycoproteinQ39684388
Optimal induction of HPV DNA vaccine-induced CD8+ T cell responses and therapeutic antitumor effect by antigen engineering and electroporationQ39817550
Rabies DNA vaccine: no impact of MHC class I and class II targeting sequences on immune response and protection against lethal challengeQ39862726
Improvement of thermostability of recombinant collagen-like protein by incorporating a foldon sequenceQ40108007
Comparison of HIV Type 1 ADA gp120 monomers versus gp140 trimers as immunogens for the induction of neutralizing antibodies.Q40466941
Protection against dengue type 2 virus induced in mice immunized with a DNA plasmid encoding the non-structural 1 (NS1) gene fused to the tissue plasminogen activator signal sequenceQ40500253
The role of position a in determining the stability and oligomerization state of alpha-helical coiled coils: 20 amino acid stability coefficients in the hydrophobic core of proteinsQ41783489
Expression of Hepatitis B virus surface antigen (HBsAg) from genotypes A, D and F and influence of amino acid variations related or not to genotypes on HBsAg detectionQ43460489
A new CRF01_AE/B recombinant structure of HIV type 1 found in Heilongjiang province, ChinaQ43700654
A buried polar residue in the hydrophobic interface of the coiled-coil peptide, GCN4-p1, plays a thermodynamic, not a kinetic role in foldingQ44078380
Structural characterization of mumps virus fusion protein coreQ44291856
Formation of highly stable chimeric trimers by fusion of an adenovirus fiber shaft fragment with the foldon domain of bacteriophage t4 fibritinQ44709116
Immunization with plasmid DNA encoding influenza A virus nucleoprotein fused to a tissue plasminogen activator signal sequence elicits strong immune responses and protection against H5N1 challenge in miceQ45391069
Targeting the vaccinia virus L1 protein to the cell surface enhances production of neutralizing antibodies.Q45394935
A comparative immunogenicity study in rabbits of disulfide-stabilized, proteolytically cleaved, soluble trimeric human immunodeficiency virus type 1 gp140, trimeric cleavage-defective gp140 and monomeric gp120.Q45409784
Anthrax protective antigen administered by DNA vaccination to distinct subcellular locations potentiates humoral and cellular immune responsesQ46171221
An HMM model for coiled-coil domains and a comparison with PSSM-based predictions.Q52040275
A Neural Network Method for Identification of Prokaryotic and Eukaryotic Signal Peptides and Prediction of their Cleavage SitesQ57825167
Configuration of influenza hemagglutinin fusion peptide monomers and oligomers in membranesQ58322975
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)731-740
P577publication date2011-05-10
P1433published inApplied Microbiology and BiotechnologyQ13553694
P1476titleImproved expression of secretory and trimeric proteins in mammalian cells via the introduction of a new trimer motif and a mutant of the tPA signal sequence.
P478volume91

Reverse relations

cites work (P2860)
Q40195280A method for the isolation and characterization of functional murine monoclonal antibodies by single B cell cloning
Q34784825An HIV-1 envelope immunogen with W427S mutation in CD4 binding site induced more T follicular helper memory cells and reduced non-specific antibody responses.
Q40452508Comparison of the patterns of antibody recall responses to HIV-1 gp120 and hepatitis B surface antigen in immunized mice.
Q100517406DNA adjuvant Amiloride conjunct long immunization interval promote higher antibody responses to HIV-1 gp41 and gp140 immunogens
Q64930831Divergent Primary Immune Responses Induced by Human Immunodeficiency Virus-1 gp120 and Hepatitis B Surface Antigen Determine Antibody Recall Responses.
Q89511484Immunogenicity of HIV-1 Vaccines Expressing Chimeric Envelope Glycoproteins on the Surface of Pr55 Gag Virus-Like Particles
Q36121964Lentiviral expression system for the purification of secreted proteins from human cell cultures.
Q104506690Modifications to the HIV-1 SAAVI MVA-C vaccine improve in vitro expression and in vivo immunogenicity
Q47281170Plasmodium yoelii S4/CelTOS is important for sporozoite gliding motility and cell traversal
Q57009763Potent HIV-1-Specific CD8 T Cell Responses Induced in Mice after Priming with a Multiepitopic DNA-TMEP and Boosting with the HIV Vaccine MVA-B
Q27333522Structure-based design of head-only fusion glycoprotein immunogens for respiratory syncytial virus

Search more.